Published in Nouv Presse Med on June 03, 1978
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone (2000) 2.06
Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int (2007) 1.70
The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology (1972) 1.63
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporos Int (1997) 1.43
Vitamin D metabolites and bone mineralization in man. J Clin Endocrinol Metab (1978) 1.27
Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int (2001) 1.19
Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res (1983) 1.17
Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases. Br Med J (Clin Res Ed) (1984) 1.14
Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol (1996) 1.13
Agenesis of the right pulmonary artery in a young asymptomatic girl. Eur Respir J (1991) 1.11
Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab (1993) 1.10
Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome. Clin Immunol Immunopathol (1995) 1.07
High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina. Eur J Clin Nutr (2004) 1.06
Professional football (soccer) players have a markedly greater skeletal mineral content, density and size than age- and BMI-matched controls. Calcif Tissue Int (1998) 1.02
Risk for developing osteoporosis in untreated premature menopause. Calcif Tissue Int (1992) 1.01
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ (1992) 1.00
The prevalence of chondrocalcinosis in the human knee joint. An autopsy survey. J Rheumatol (1988) 0.99
Pseudohypoparathyroidism 1942-1966. A negative progress report. Am J Med (1967) 0.98
Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int (1989) 0.96
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum (1996) 0.95
Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest (1991) 0.94
LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone (2005) 0.94
Circadian rhythm of urinary total and free hydroxyproline excretion and its relation to creatinine excretion. J Lab Clin Med (1970) 0.94
Bone mineral density of the spine and radius shaft in children with X-linked hypophosphatemic rickets (XLH). Bone Miner (1991) 0.94
Osteocalcin and bone morphometric parameters in adults without bone disease. Calcif Tissue Int (1988) 0.93
Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res (1993) 0.92
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Curr Med Res Opin (2007) 0.91
Effects of prostaglandins on human hematopoietic osteoclast precursors. Endocrinology (1997) 0.91
Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocrinol Metab (1982) 0.91
Estradiol inhibits adhesion and promotes apoptosis in murine osteoclasts in vitro. J Steroid Biochem Mol Biol (2006) 0.91
Effects of iron overload on bone remodeling in pigs. Am J Pathol (1984) 0.89
Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3. Am J Hum Genet (2001) 0.89
Decreased bone formation in osteoporotic patients compared with age-matched controls. Calcif Tissue Int (1989) 0.89
The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1974) 0.88
17beta-estradiol downregulates beta3-integrin expression in differentiating and mature human osteoclasts. J Cell Physiol (2004) 0.88
Bone histological heterogeneity in postmenopausal osteoporosis: a sequential histomorphometric study. Bone (1987) 0.87
Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma. Bone (1994) 0.87
Bone histomorphometric reproducibility in normal patients. Calcif Tissue Int (1981) 0.87
The visualization and evaluation of bone architecture in the rat using three-dimensional X-ray microcomputed tomography. J Bone Miner Metab (1999) 0.86
Effect of low doses of stable strontium on bone metabolism in rats. Miner Electrolyte Metab (1985) 0.86
Bone changes in adult patients with abnormal thyroid function (with special reference to 45Ca kinetics and quantitative histology). Proc R Soc Med (1967) 0.86
Familial idiopathic hyperphosphatasia (FIH): response to long-term treatment with pamidronate (APD). Bone Miner (1992) 0.86
Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia. J Clin Densitom (2001) 0.86
[Bone involvement in primary oxalosis. Study of 20 cases]. Rev Rhum Mal Osteoartic (1991) 0.86
Seasonal variations of 25 hydroxyvitamin D and parathyroid hormone in Ushuaia (Argentina), the southernmost city of the world. Bone Miner (1993) 0.85
Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cells. J Bone Miner Res (2000) 0.85
Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy. J Clin Endocrinol Metab (1989) 0.85
[Cellular aspects of the aging of the articular cartilage. II. Condylar cartilage with fissured surface taken from normal and arthritic knees]. Rev Rhum Mal Osteoartic (1984) 0.85
Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis. Osteoporos Int (1991) 0.85
The treatment of Paget's bone disease with sodium ethidronate. Am J Med Sci (1979) 0.84
[Cellular aspects of the aging of articular cartilage. I. Condylar cartilage with a normal surface sampled from normal knees]. Rev Rhum Mal Osteoartic (1984) 0.84
Potentiation of transforming growth factor (TGF-beta 1) by natural coral and fibrin in a rabbit cranioplasty model. Calcif Tissue Int (1994) 0.83
Formation of multinucleated cells with osteoclast precursor features in human cord monocytes cultures. Anat Rec (1990) 0.83
[Vitamin-resistant hypophosphatemic rickets and spinal cord compression. Apropos of 2 cases]. Rev Rhum Ed Fr (1993) 0.83
Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int (1987) 0.83
Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Hum Mol Genet (1998) 0.83
The effect of sodium fluoride on trabecular architecture. Bone (1991) 0.83
[Axial osteosclerosis with autosomal dominant transmission: a new entity?]. Rev Rhum Mal Osteoartic (1979) 0.82
New factors controlling bone remodeling. Joint Bone Spine (2000) 0.82
Reference intervals for vitamins B1, B2, E, D, retinol, beta-carotene, and folate in blood: usefulness of dietary selection criteria. Clin Chem (1986) 0.82
Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology (1991) 0.82
Effect of oestradiol on cytokine production in immortalized human marrow stromal cell lines. Cytokine (2001) 0.82
Plasma bone-specific alkaline phosphatase changes in hemodialysis patients treated by alfacalcidol. Clin Nephrol (2002) 0.82
Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J Clin Endocrinol Metab (1989) 0.82
1,25-dihydroxyvitamin D3 induces NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human neonatal monocytes. Blood (1997) 0.82
Malignant hypercalcemia induced by a parathyroid hormone-related protein secreted by a cutaneous squamous cell carcinoma. Arch Dermatol (1997) 0.82
1,25-Dihydroxycholecalciferol effect on serum phosphorus homeostasis in rats. Endocrinology (1976) 0.82
Bone changes due to pregnancy and lactation: influence of vitamin D status. Am J Physiol (1986) 0.81
PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant (1996) 0.81
Increased proliferation of osteoblast precursor cells in estrogen-deficient rats. Am J Physiol (1993) 0.81
Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop Relat Res (1992) 0.81
Parathyroid hormone and vertebral osteosclerosis in uremic patients. Metabolism (1976) 0.81
Hyperthyroidism influences ultrasound bone measurement on the Os calcis. Osteoporos Int (1998) 0.81
[Bone remodeling: evaluation methods]. Rev Prat (1998) 0.81
Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation. Calcif Tissue Int (1997) 0.81
Proliferation of bone surface-derived osteoblastic cells and control of bone formation. Bone (1993) 0.81
Efficacy of the bisphosphonate APD in the control of Paget's bone disease. Bone (1985) 0.81
Tertiary hyperparathyroidism diagnosed after renal homotransplantation. Am J Med (1970) 0.81
The development of a European questionnaire for quality of life in patients with vertebral osteoporosis. Scand J Rheumatol Suppl (1996) 0.81
Bone mass in totally thyroidectomized patients. Role of calcitonin deficiency and exogenous thyroid treatment. Acta Endocrinol (Copenh) (1991) 0.80
Letter: Circadian rhythm of the total hydroxyproline: creatinine ratio in urine. Clin Sci Mol Med (1974) 0.80
Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH. Bone (2006) 0.80
Influence of the menopausal age on the severity of osteoporosis in women with vertebral fractures. Maturitas (1994) 0.80
Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients. Nephrol Dial Transplant (1995) 0.79
[Multiple bony fissures during treatment of osteoporosis with sodium fluoride]. Rev Rhum Mal Osteoartic (1980) 0.79
A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women. Osteoporos Int (2000) 0.79
Bone hypertrophy and trabecular generation in Paget's disease and in fluoride-treated osteoporosis. Bone Miner (1992) 0.79
European origin of patients with Paget's disease of bone in the Buenos Aires area. Eur J Epidemiol (2001) 0.79
Acute effects of Solanum malacoxylon on bone formation rates in growing rats. Calcif Tissue Int (1979) 0.78
Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone. J Bone Miner Res (1989) 0.78
Vitamin D3 sulfoconjugate in pregnant and lactating mother rats after dosing with 3H vitamin D3. Steroids (1980) 0.78